The unified social credit code/registration number of Heiske Pharmaceutical Group Co., Ltd. is 91542200741928586e, and the enterprise is in the state of opening.
The business scope of Haisike Pharmaceutical Group Co., Ltd. is: Chinese patent medicines, chemical raw materials and their preparations, antibiotics, biochemical drugs and biological products (excluding preventive biological products and diagnostic drugs). Sales: chemical raw materials (excluding inflammable, explosive and highly toxic chemical raw materials), pharmaceutical excipients and class I, II and III medical devices; 6822 medical optical instruments, instruments and endoscopic equipment; Research, development, technical service and technology transfer of Chinese and western medicines and new products; Design, production and agency; Import and export trade. Corporate brand maintenance and promotion, corporate image planning, corporate marketing management consulting, marketing management training, network data services, housing rental. (Projects subject to approval according to law can only be operated after approval by relevant departments). In Xizang Autonomous Region, the total registered capital of companies with similar business scope is 24,265,438+10,000 yuan, and the main capital is concentrated in enterprises with a scale of more than 50 million, with * * * 1 company. Within the scope of this province, the registered capital of mobile enterprises belongs to the general.
Haisike Pharmaceutical Group Co., Ltd. has invested in 10 companies and owned 1 0 branches.
See more information and materials of Haisike Pharmaceutical Group Co., Ltd. through Baidu Enterprise Credit.